Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders
NCT ID: NCT05390086
Last Updated: 2025-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2022-06-15
2022-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, diagnosis of infantile thiamine deficiency is challenging due to the highly variable, non-specific clinical manifestations, referred to as thiamine deficiency disorders (TDD), that often overlap with other conditions, resulting in misdiagnosis and missed treatment opportunities, which can be fatal or have irreversible consequences. Considering that breastfed infants are at highest risk, a large proportion of infant deaths could be avoided if: 1) infants with TDD were immediately treated with thiamine when medically indicated and, importantly; 2) thiamine deficiency was prevented by improving thiamine status among breastfeeding women. The latter is important given emerging evidence of long-term neurocognitive deficits of severe and even subclinical thiamine deficiency.
In light of these diagnostic uncertainties, it was recognised that a case definition for thiamine responsive disorders (TRD) would help to better identify infants with TDD who would benefit from timely thiamine treatment. This study will test the usefulness of a recently developed case definition for TRD and practical tool in different contexts in Lao PDR where TDD have been reported. Secondly, data on diet, maternal and household risk factors for TDD in different contexts will be used to propose a community risk factor screening tool to better identify populations at risk of thiamine deficiency and help advocate for and guide planning of preventive programmes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thiamine Responsive Disorders (TRD) Among Infants in Lao PDR
NCT03626337
Trial of Thiamine Supplementation in Cambodia
NCT03616288
Efficacy of Vitamin A Fortified Rice in Lactating Thai Women
NCT03056625
Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia
NCT02221063
Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic Drugs
NCT03989700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objective is to explore risk factors associated with TDD/TRD among infants and young children and their mothers. This will help to identify potential metrics that could be included in a community risk factor screening tool to identify population groups at risk of thiamine deficiency so appropriate preventive interventions can be implemented. Data will be collected on diet and household risk factors for thiamine deficiency, including infant and young child feeding practices, maternal dietary practices, maternal health status and household socioeconomic status and food security.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of care
The study is being implemented among children who are seeking care at collaborating hospitals for signs and symptoms suggestive of TDD. All children will be treated by the hospital physicians following the usual hospital procedures. The study will not interfere in any with the administration of required treatments and interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enlarged liver (liver edge \>2 cm below the right costal margin)
* Edema
* Tachypnea (respiratory rate \>60/min for 3-8 weeks; \>50/min for 2-11 months; \>40/min for 12-18 months)
* Tachycardia (heart rate \>160/min for \<12 months; \>120/min for 12-18 months)
* Oxygen saturation \<92%
* Difficulty breathing (chest indrawing or nasal flaring)
* Refusal to breastfeed or of infant formula or food for \>24 hours
* Repetitive or recurrent vomiting with no obvious other cause (\>3 times in past 24 hours)
* Persistent crying not relieved by soothing or feeding with no obvious other cause
* Hoarse voice/cry or loss of voice
* Nystagmus or other unusual eye movements
* Muscle twitching
* Loss of consciousness
* Convulsion
* Opisthotonos/abnormal posturing
* Acute/flaccid paralysis
Exclusion Criteria
21 Days
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lao Tropical and Public Health Institute
OTHER_GOV
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lao Friends Hospital for Children
Luang Prabang, , Laos
Children's Hospital
Vientiane, , Laos
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1867468
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.